Clinical Trial Update: Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial update on M518101 for plaque psoriasis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• M518101

Snippet

Sponsor: Maruho North America Inc. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED